Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1627 1654
This examiner grants 63% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18290347 | NEW SUBSTITUTED PYRIDINES AS FUNGICIDE | Non-Final OA | BASF SE |
| 18270581 | USE OF KRAS G12C INHIBITOR IN TREATING CANCERS | Non-Final OA | AMGEN INC. |
| 18004656 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF FIBROTIC DISEASES AND CANCER | Final Rejection | Purdue Research Foundation |
| 17996898 | COMPOUNDS FOR THE TREATMENT OF SARS | Non-Final OA | PURDUE RESEARCH FOUNDATION |
| 18006760 | FAP-ACTIVATED COMPOUNDS FOR TREATMENT OF CANCER | Non-Final OA | The Johns Hopkins University |
| 17615402 | PROCASPASE-3 ACTIVATION AND IMMUNOTHERAPY FOR TREATMENT OF CANCER | Non-Final OA | The Board of Trustees of the University of Illinois |
| 17584663 | RAPID RELIEF OF MOTOR FLUCTUATIONS IN PARKINSON'S DISEASE | Final Rejection | Merz Pharmaceuticals, LLC |
| 18578066 | Serotonin 5-HT2A, 5-HT2B, and 5-HT2C Receptor Inverse Agonists | Non-Final OA | Northeastern University |
| 18396305 | COPPER CHELATOR, ANTICANCER AGENT AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR WILSON'S DISEASE | Non-Final OA | National University Corporation Hokkaido University |
| 17761737 | SMALL-MOLECULE INHIBITORS FOR THE B-CATENIN/B-CELL LYMPHOMA 9 PROTEIN-PROTEIN INTERACTION | Non-Final OA | H. Lee Moffitt Cancer Center and Research Institute, Inc. |
| 18250530 | Macrophage Migration Inhibitory Factor Inhibitors, and Methods of Making and Using Same | Non-Final OA | YALE UNIVERSITY |
| 18251868 | INHIBITION OF GLYCOGEN SYNTHASE KINASE-3 (GSK-3) | Non-Final OA | Brown University |
| 18042748 | CRF RECEPTOR ANTAGONISTS AND METHODS OF USE | Final Rejection | Neurocrine Biosciences, Inc. |
| 18034649 | DRUGS TARGETING INFLAMMATION FOR THE TREATMENT OF OSTEOARTHRITIS AND OTHER INFLAMMATORY DISEASES | Non-Final OA | The United States Government as Represented by the Department of Veterans Affairs |
| 18249766 | METALLIC TRANS-(N-HETEROCYCLIC CARBENE)-AMINE-PLATINUM COMPLEXES AND USES THEREOF FOR TREATING CANCER | Non-Final OA | UNIVERSITE PARIS-SACLAY |
| 18565673 | USE OF COMPOSITION OF ALCOHOL AND COOLING AGENT IN REGULATING SEXUAL FUNCTIONS, PROTECTING CARDIOVASCULAR AND CEREBROVASCULAR SYSTEMS, PROMOTING REGENERATION OF LIVER CELLS, PREVENTING AND/OR TREATING TUMORS, AND IMPROVING IMMUNITY AND SLEEP QUALITY | Non-Final OA | QINGHAI SPRING MEDICINAL RESOURCES TECHNOLOGY CO.,LTD. |
| 18562643 | USE OF PYRROLOPYRIMIDINE COMPOUND | Non-Final OA | GUANGZHOU JOYO PHARMATECH CO., LTD |
| 18559951 | FUSED HETEROCYCLIC DERIVATIVES AS NEGATIVE ALLOSTERIC MODULATORS OF MGLU7 RECEPTOR | Non-Final OA | Addex Pharma S.A. |
| 18560076 | NOVEL FORMS OF ENTINOSTAT | Non-Final OA | Macfarlan Smith Limited |
| 18559411 | USE OF CLOFOCTOL FOR THE TREATMENT OF INFLAMMATION | Final Rejection | APTEEUS |
| 17757530 | COMBINATIONS | Final Rejection | Recurium IP Holdings, LLC |
| 18471563 | PHARMACEUTICAL COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF A DISEASE OR DISORDER CAUSED BY OR ASSOCIATED WITH ONE OR MORE PREMATURE TERMINATION CODONS | Non-Final OA | Monte Rosa Therapeutics AG |
| 18266970 | OLIGONUCLEOTIDE ANALOGUE THERAPEUTICS FOR TREATMENT OF NEUROMUSCULAR DISEASE | Non-Final OA | NeuBase Therapeutics, Inc. |
| 17996113 | MOLECULES FOR USE IN THE TREATMENT OF VIRAL INFECTIONS | Final Rejection | UNIVERSITA' DEGLI STUDI DI MILANO |
| 18196962 | INHALED LIQUID FOR THE TREATMENT OF RESPIRATORY INFECTIONS IN HUMANS CAUSED BY PATHOGENS RESISTANT TO ANTIBIOTICS | Non-Final OA | CONICK BIOTECH LLC |
| 18032998 | HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES | Non-Final OA | Zoetis LLC |
| 18026068 | DEUTERATED PARAXANTHINE AND USES THEREOF | Final Rejection | Lennham Pharmaceuticals, Inc. |
| 17923707 | AKT3 MODULATORS | Non-Final OA | Georgiamune Inc. |
| 17959470 | THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-gp INHIBITOR FOR THE TREATMENT OF CANCER | Non-Final OA | Athenex Therapeutics Limited |
| 17795047 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | Non-Final OA | KayoThera Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy